MicroRNAs (MiRs) Precisely Regulate Immune System Development and Function in Immunosenescence Process

International Reviews of Immunology

Volumn 35, Issue 1, 2016, Pages 57-66

  Aalaei Andabili, Seyed Hossein ^a   Rezaei, Nima ^b,c,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

aging; immunosenescence; microRNA; systematic review

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MICRORNA 146A; MICRORNA 223; MICRORNA 29; CYTOKINE; LIPOPOLYSACCHARIDE;

AGING; APOPTOSIS; CD8+ T LYMPHOCYTE; DOWN REGULATION; GENE CONTROL; GENE TARGETING; HUMAN; IMMUNE SYSTEM; IMMUNOSENESCENCE; MACROPHAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; IMMUNOSENESCENCE; LIPOPOLYSACCHARIDES; MICE; MICRORNAS; NEUTROPHILS; NF-KAPPA B; T-LYMPHOCYTES;

EID: 84940484884     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2015.1077828     Document Type: Review

References (56)

1. Spazzafumo L, Olivieri F, Abbatecola AM, et al. Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr). 2011. Epub 2011/12/17.
2. Cevenini E, Bellavista E, Tieri P, et al. Systems biology and longevity: An emerging approach to identify innovative anti-aging targets and strategies. Curr Pharm Des. 2010;16(7):802-13. Epub 2010/04/15.
3. Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118(1):75-86. Epub 1988/01/01.
4. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature. 2011;479(7372):232-6. Epub 2011/11/04.
5. Jiang M, Xiang Y, WangD, et al. Dysregulated expression of miR-146a contributes to age-related dysfunction ofmacrophages. Aging Cell. 2012;11(1):29-40. Epub 2011/10/11.
6. Frasca D, Landin AM, Riley RL, Blomberg BB. Mechanisms for decreased function of B cells in aged mice and humans. J Immunol. 2008;180(5):2741-6. Epub 2008/02/23.
7. Van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol. 2007;178(2):970-5. Epub 2007/01/05.
8. Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev. 1997;160:55-62. Epub 1998/02/26.
9. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5(2):133-9. Epub 2004/01/30.
10. Zheng B, Han S, Takahashi Y, KelsoeG. Immunosenescence and germinal center reaction. Immunol Rev. 1997;160:63-77. Epub 1998/02/26.
11. Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophils by TNFrelated apoptosis-inducing [corrected] ligand. J Immunol. 2005;175(2):1232-8. Epub 2005/07/09.
12. Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NFkappa B recruitment. Nat Immunol. 2002;3(1):69-75. Epub 2001/12/18.
13. Bhaumik D, Scott GK, Schokrpur S, et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging. 2009;1(4):402-11. Epub 2010/02/12.
14. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163-75. Epub 2011/02/19.
15. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol. 2008;20(2):214-21. Epub 2008/03/11.
16. Aalaei-Andabili SH, Rezaei N. Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) promotes proper immune response against infections: A systematic review. J Infect. 2013;67(4):251-64. Epub 2013/07/16.
17. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316(5824):608-11. Epub 2007/04/28.
18. Johnnidis JB, HarrisMH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function bymicroRNA-223. Nature. 2008;451(7182):1125-9. Epub 2008/02/19.
19. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8):5082-9. Epub 2007/10/04.
20. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97. Epub 2004/01/28.
21. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann New York Acad Sci. 2000;908:244-54. Epub 2000/07/27.
22. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6. Epub 2006/08/04.
23. Ceppi M, Pereira PM, Dunand-Sauthier I, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A. 2009;106(8):2735-40. Epub 2009/02/06.
24. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511. Epub 2004/07/02.
25. Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer inmice. J ExpMed. 2011;208(6):1189-201. Epub 2011/05/11.
26. Zhao JL, Rao DS, BoldinMP, et al. NF-kappaB dysregulation in microRNA-146a-deficientmice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A. 2011;108(22):9184-9. Epub 2011/05/18.
27. Olivieri F, Lazzarini R, Recchioni R, et al. MiR-146a as marker of senescence-associated proinflammatory status in cells involved in vascular remodelling. Age (Dordr). 2012. Epub 2012/ 06/14.
28. Rodier F, Coppe JP, Patil CK, et al. PersistentDNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nature Cell Biol. 2009;11(8):973-9. Epub 2009/07/15.
29. Olivieri F, Procopio AD, Montgomery RR. Effect of aging on microRNAs and regulation of pathogen recognition receptors. Curr Opin Immunol. 2014;29C:29-37. Epub 2014/04/29.
30. Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS biology. 2008;6(12):2853-68. Epub 2008/12/05.
31. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Resp Crit CareMed. 1999;160(5 Pt 2):S5-11. Epub 1999/11/11.
32. Scapini P, Lapinet-Vera JA, Gasperini S, et al. Theneutrophil as a cellular source of chemokines. Immunol Rev. 2000;177:195-203. Epub 2001/01/04.
33. Lysgaard C, Nielsen MS, Christensen JH, et al. No effect of high-dose atorvastatin on leukotriene B(4) formation fromneutrophils in patients treatedwith coronary bypass surgery: A randomized placebocontrolled double-blinded trial with a crossover design. Prostaglandins Leukot Essent Fatty Acids. 2012;87(6):185-8. Epub 2012/10/16.
34. Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980;286(5770):264-5. Epub 1980/07/17.
35. Ward JR, Heath PR, Catto JW, et al. Regulation of neutrophil senescence by microRNAs. PLoS One. 2011;6(1):e15810. Epub 2011/02/02.
36. Martin C, Burdon PC, Bridger G, et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003;19(4):583-93. Epub 2003/10/18.
37. Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res. 2009;43(1-3):25-61. Epub 2008/12/11.
38. Colotta F, Re F, Polentarutti N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80(8):2012-20. Epub 1992/10/15.
39. Whyte MK, Savill J, Meagher LC, et al. Coupling of neutrophil apoptosis to recognition by macrophages: coordinated acceleration by protein synthesis inhibitors. J Leukoc Biol. 1997;62(2):195-202. Epub 1997/08/01.
40. Dorhoi A, IannacconeM, Farinacci M, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013;123(11):4836-48. Epub 2013/10/03.
41. Haneklaus M, Gerlic M, O'Neill LA, Masters SL. miR-223: infection, inflammation and cancer. J Int Med. 2013;274(3):215-26. Epub 2013/06/19.
42. Tsang WP, Kwok TT. Let-7amicroRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis: Int J Programmed Cell Death. 2008;13(10):1215-22. Epub 2008/09/02.
43. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulatesMcl-1 protein expression and apoptosis. Oncogene. 2007;26(42):6133-40. Epub 2007/04/04.
44. Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today. 1993;14(11):547-53. Epub 1993/11/01.
45. Li L, Hsu HC, Grizzle WE, et al. Cellular mechanism of thymic involution. Scand J Immunol. 2003;57(5):410-22. Epub 2003/05/20.
46. Virts EL, ThomanML. Age-associated changes inmiRNA expression profiles in thymopoiesis. Mech Ageing Dev. 2010;131(11-12):743-8. Epub 2010/10/12.
47. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-33. Epub 2009/01/27.
48. Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunol. 2008;9(4):405-14. Epub 2008/ 03/11.
49. Ventura A, Young AG, Winslow MM, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132(5):875-86. Epub 2008/ 03/11.
50. OhyashikiM, Ohyashiki JH, HirotaA, et al. Age-relateddecrease ofmiRNA-92a levels inhumanCD8+ T-cells correlates with a reduction of naive T lymphocytes. Immun Ageing: I & A. 2011;8(1):11. Epub 2011/11/16.
51. Salaun B, Yamamoto T, Badran B, et al. Differentiation associated regulation of microRNAexpression in vivo in human CD8+ T cell subsets. J TranslationalMed. 2011;9:44. Epub 2011/04/22.
52. Rosenberg C, Bovin NV, Bram LV, et al. Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccines Immunother. 2013;9(7):1466-76. Epub 2013/04/11.
53. Shin JI, Bayry J. An age-related decline of CD62L and vaccine response: A role of microRNA 92a? Human Vaccines Immunother. 2014;10(5):1404-1405. Epub 2014/01/10.
54. Li G, Yu M, Lee WW, et al. Decline in miR-181a expressionwith age impairs T cell receptor sensitivity by increasing DUSP6 activity. NatMed. 2012;18(10):1518-24. Epub 2012/10/02.
55. Bratic A, Larsson NG. The role of mitochondria in aging. J Clin Invest. 2013;123(3):951-7. Epub 2013/03/05.
56. Seeger T, Haffez F, Fischer A, et al. Immunosenescence-associated microRNAs in age and heart failure. Eur J Heart Fail. 2013;15(4):385-93. Epub 2012/12/22.